ADRENOCORTICAL CARCINOMA (ACC)
Clinical trials for ADRENOCORTICAL CARCINOMA (ACC) explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA (ACC) trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA (ACC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation approach tested for Tough-to-Treat adrenal cancer
Disease control Recruiting nowThis study is testing if giving radiation therapy before surgery is safe for people with a rare adrenal gland cancer that has come back. Up to 32 adults whose cancer can be surgically removed will receive a few weeks of radiation, followed by surgery about a month later. The main…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New immune drug targets liver tumors in advanced cancer trial
Disease control Recruiting nowThis study is testing whether adding a new immune-stimulating drug called PDS01ADC to a specialized liver cancer treatment can better control advanced cancers that have spread to the liver. The treatment involves surgically placing a pump that delivers chemotherapy directly to th…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC